|
Acute myocardial infarction
Citations 81-90 of 122 total displayed.
|
Past content
(since Nov 1999):
|
- Clinical Research
Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction
- Francisco Fernández-Avilés, José Alberto San Román, Javier García-Frade, María Eugenia Fernández, María Jesús Peñarrubia, Luis de la Fuente, Manuel Gómez-Bueno, Alberto Cantalapiedra, Jesús Fernández, Oliver Gutierrez, Pedro L. Sánchez, Carolina Hernández, Ricardo Sanz, Javier García-Sancho, and Ana Sánchez
Circ. Res. 2004;95:742-748; published online before print as doi:10.1161/01.RES.0000144798.54040.ed
[Abstract]
[Full text]
- Ultrarapid Communication
Inhibition of Cytochrome P450 -Hydroxylase. A Novel Endogenous Cardioprotective Pathway
- Kasem Nithipatikom, Eric R. Gross, Michael P. Endsley, Jeannine M. Moore, Marilyn A. Isbell, John R. Falck, William B. Campbell, and Garrett J. Gross
Circ. Res. published September 23, 2004, doi:10.1161/01.RES.0000146277.62128.6f
[Abstract]
- Articles
Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction
- Francisco Fernández-Avilés, José Alberto San Román, Javier García-Frade, María Eugenia Fernández, María Jesús Peñarrubia, Luis de la Fuente, Manuel Gómez-Bueno, Alberto Cantalapiedra, Jesús Fernández, Oliver Gutierrez, Pedro L. Sánchez, Carolina Hernández, Ricardo Sanz, Javier García-Sancho, and Ana Sánchez
Circ. Res. published September 9, 2004, doi:10.1161/01.RES.0000144798.54040.ed
[Abstract]
- Special Articles
Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy
- Roberto Bolli, Lance Becker, Garrett Gross, Robert Mentzer, Jr, David Balshaw, and David A. Lathrop
Circ. Res. 2004;95:125-134, doi:10.1161/01.RES.0000137171.97172.d7
[Abstract]
[Full text]
- Reviews
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
- Mark F. Pittenger and Bradley J. Martin
Circ. Res. 2004;95:9-20, doi:10.1161/01.RES.0000135902.99383.6f
[Abstract]
[Full text]
- Reviews
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
- Min Nian, Paul Lee, Neelam Khaper, and Peter Liu
Circ. Res. 2004;94:1543-1553, doi:10.1161/01.RES.0000130526.20854.fa
[Abstract]
[Full text]
- Reviews
Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican
- Thomas N. Wight and Mervyn J. Merrilees
Circ. Res. 2004;94:1158-1167, doi:10.1161/01.RES.0000126921.29919.51
[Abstract]
[Full text]
- Integrative Physiology
Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction
- Stefan Janssens, Peter Pokreisz, Luc Schoonjans, Marijke Pellens, Pieter Vermeersch, Marc Tjwa, Peter Jans, Marielle Scherrer-Crosbie, Michael H. Picard, Zsolt Szelid, Hilde Gillijns, Frans Van de Werf, Desire Collen, and Kenneth D. Bloch
Circ. Res. 2004;94:1256-1262; published online before print as doi:10.1161/01.RES.0000126497.38281.23
[Abstract]
[Full text]
- Integrative Physiology
Opioid-Induced Cardioprotection Occurs via Glycogen Synthase Kinase ß Inhibition During Reperfusion in Intact Rat Hearts
- Eric R. Gross, Anna K. Hsu, and Garrett J. Gross
Circ. Res. 2004;94:960-966; published online before print as doi:10.1161/01.RES.0000122392.33172.09
[Abstract]
[Full text]
- Articles
Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction
- Stefan Janssens, Peter Pokreisz, Luc Schoonjans, Marijke Pellens, Pieter Vermeersch, Marc Tjwa, Peter Jans, Marielle Scherrer-Crosbie, Michael H. Picard, Zsolt Szelid, Hilde Gillijns, Frans Van de Werf, Desire Collen, and Kenneth D. Bloch
Circ. Res. published March 25, 2004, doi:10.1161/01.RES.0000126497.38281.23
[Abstract]
|
|
